Geneos Wealth Management’s AllianzIM U.S. Equity Buffer10 Jan ETF JANT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.96K Hold
90
﹤0.01% 2232
2026
Q1
$3.61K Hold
90
﹤0.01% 2222
2025
Q4
$3.71K Sell
90
-56
-38% -$2.26K ﹤0.01% 2215
2025
Q3
$5.81K Buy
+146
New +$5.66K ﹤0.01% 2109

Other funds holding JANT

Geneos Wealth Management's JANT Position: Q2 2026 in Review

Geneos Wealth Management held its AllianzIM U.S. Equity Buffer10 Jan ETF (JANT) position steady in Q2 2026 at 90 shares worth $3.96K. The position accounts for ﹤0.01% of the portfolio, ranked #2232.

Geneos Wealth Management first reported a position in JANT in Q3 2025 and has held it in 4 quarters since. The position peaked at $5.81K in Q3 2025. 31 funds tracked by Wall St. Rank hold JANT as of Q2 2026.

  • Geneos Wealth Management held 90 shares of AllianzIM U.S. Equity Buffer10 Jan ETF worth $3.96K as of Q2 2026.
  • Geneos Wealth Management left its AllianzIM U.S. Equity Buffer10 Jan ETF share count unchanged in Q2 2026.
  • AllianzIM U.S. Equity Buffer10 Jan ETF made up ﹤0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #2232 holding.
  • Geneos Wealth Management first reported a position in AllianzIM U.S. Equity Buffer10 Jan ETF in Q3 2025 and has held it in 4 quarters since.
  • Geneos Wealth Management's AllianzIM U.S. Equity Buffer10 Jan ETF position peaked at $5.81K in Q3 2025.
  • 31 funds tracked by Wall St. Rank held AllianzIM U.S. Equity Buffer10 Jan ETF as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.